News
Valneva must immediately cease U.S. shipments and sales of Ixchiq, a vaccine for chikungunya virus. The FDA recently lifted a ...
The U.S. Food and Drug Administration (USFDA) has suspended the biologics license of Ixchiq (Chikungunya Vaccine, Live), ...
21h
MedPage Today on MSNIn Abrupt Reversal, FDA Yanks Ixchiq Vaccine Over Safety Concern
According to the vaccine's maker, Valneva, the FDA based its decision to suspend the shot on four new serious adverse events ...
The US Food and Drug Administration (FDA) announced late last week that it has suspended the license for French drugmaker ...
The agency said it had become aware of more reports of serious adverse events, leading center director Vinay Prasad to ...
Shares of French drugmaker Valneva slumped more than 20% on Monday after the U.S. Food and Drug Administration suspended the ...
The United States Food and Drug Administration (FDA) has suspended the licence of one of the two chikungunya vaccines ...
US health authorities have suspended the license for the Ixchiq vaccine against the chikungunya virus following reports of ...
The FDA Adverse Event Reporting System, which Commissioner Marty Makary called “clunky,” previously published updates on a ...
A new study has exposed “serious adverse events" linked to mifepristone, also known as the “abortion pill." Researchers and experts discuss the risks.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results